Nureca Limited has informed the Exchange regarding Re-Appointment of Saurabh Goyal as Managing Director of the company for a period of 3 years w.e.f. September 03, 2026.
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nureca Limited's board meeting on May 29, 2026 approved multiple items. Key financials show FY26 revenue of Rs 1,472.10 million (up from Rs 1,146.40 million in FY25), though Q4 FY26 posted a loss of Rs 61.52 million due to a Rs 83.37 million fair value loss on investments. Net profit after tax for FY26 was Rs 2.97 million, a turnaround from a loss of Rs 6.68 million in FY25. The board approved a Rs 100 crore capex for new plant and machinery at its Derabassi facility and the purchase of adjoining land for future expansion. On the leadership front, CFO Mr. Naresh Gupta resigned effective June 26, 2026, and Mr. Chander Kant was promoted internally to CFO. The board also reappointed Mr. Saurabh Goyal (Managing Director) and Mr. Aryan Goyal (CEO & Whole-time Director) for 3 years each, and appointed Ms. Smita Goyal as Additional Director (Whole-time Director). All appointments are subject to shareholder approval at the July 28, 2026 AGM.
The CFO resignation followed by an immediate internal replacement may raise short-term concerns, but the internal promotion signals continuity. The expansion capex and land purchase signal growth ambitions, while the family-run board structure remains intact, with the Goyal family controlling a significant majority of shares.